Algorae Chair Adds Shares Through On-Market Trade
1AI: $0.009 +0.00% · MC: $18M
Algorae Pharmaceuticals chairman David Hainsworth acquired additional shares through an on-market trade held indirectly via Cathedral Estate, increasing that holding. The notice reports no change to his direct holdings or other disclosed interests.

Comments